Want to see PMHS full AI Analyst Report?
PMHS Stock Chart & Stats
$0.20
-$0.02(-18.75%)
At close: 4:00 PM EDT
$0.20
-$0.02(-18.75%)
Day’s Range― - ―
52-Week Range$0.07 - $0.80
Previous CloseN/A
Volume100.00
Average Volume (3M)7.24K
Market Cap
$3.41M
Enterprise Value$3.93M
Total Cash (Recent Filing)$178.87K
Total Debt (Recent Filing)$794.79K
Price to Earnings (P/E)―
Beta-1.06
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding28,380,869
10 Day Avg. Volume10,471
30 Day Avg. Volume7,239
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-18.17
Price to Sales (P/S)34.26
P/FCF Ratio-56.08
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue1.24
Enterprise Value/Gross Profit2.02
Enterprise Value/Ebitda-45.67
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Gross MarginRapid revenue expansion combined with a solid gross margin indicates meaningful customer or service growth and preserves economic value on sales. If the company can improve operating discipline, this revenue base could provide a foundation for better absorption of fixed costs and stronger future earnings.
No Reported Total DebtThe absence of reported total debt avoids immediate interest and refinancing pressure, giving management more flexibility than a similarly loss-making company with substantial borrowings. This can help preserve strategic options while the company works to improve profitability and cash generation.
Governance And Financial Leadership RefreshAdding an experienced CFO and refreshing board oversight could strengthen financial controls, reporting discipline, and strategic accountability. The new committee and governance changes are particularly relevant because improved oversight may support more credible capital allocation and execution over the coming quarters.
Bears Say
Extreme Operating And Net LossesLosses of this magnitude show that the current cost structure is not scaling with revenue, despite strong gross profitability. Unless operating expenses are materially reduced or revenue growth accelerates further, persistent losses could consume resources and prevent the business from converting its commercial progress into sustainable earnings.
Negative Stockholders’ EquityNegative equity indicates an impaired capitalization base and leaves the company with limited financial flexibility. It can make future funding more consequential, increase dependence on external capital, and raise the possibility that financing terms or additional equity issuance will affect existing stakeholder interests.
Persistent Negative Cash FlowOngoing operating and free cash outflows mean the company is not yet self-funding its operations, even though TTM cash burn improved versus 2025. Continued reliance on financing can constrain investment choices and remains a durable risk while large net losses persist.
Polomar Health Services News
PMHS FAQ
What was Polomar Health Services’s price range in the past 12 months?
Polomar Health Services lowest stock price was $0.07 and its highest was $0.80 in the past 12 months.
What is Polomar Health Services’s market cap?
Polomar Health Services’s market cap is $3.41M.
When is Polomar Health Services’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Polomar Health Services’s earnings last quarter?
Currently, no data Available
Is Polomar Health Services overvalued?
According to Wall Street analysts Polomar Health Services’s price is currently Overvalued.
Does Polomar Health Services pay dividends?
Polomar Health Services does not currently pay dividends.
What is Polomar Health Services’s EPS estimate?
Polomar Health Services’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Polomar Health Services have?
Polomar Health Services has 28,380,869 shares outstanding.
What happened to Polomar Health Services’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Polomar Health Services?
Currently, no hedge funds are holding shares in PMHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Polomar Health Services
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
Technical Analysis
PainReform
―
Universe Pharmaceuticals
―
Bluejay Diagnostics
―
NewGenIvf Group
―
Mobile-health Network Solutions Class A
―
Ownership Overview
0.50% Insiders
―
Mutual Funds
― Other Institutional Investors
99.50% Public Companies and
Individual Investors